Developing cell-based therapies for pancreatic ductal adenocarcinoma
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci189513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Rachel Elizabeth Ann Fincham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Antigens, Neoplasm, Neoplasm Proteins. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.
- Centre for Quantitative Medicine, Duke-National University of Singapore (NUS) Medical School, Singapore.
- Cancer Science Institute of Singapore, National University of Singapore, Singapore.
- Barts and the London Hepato-Pancreato-Biliary (HPB) Centre, The Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom.
Zitieren
APA
Fincham, R. E. A., Yeong, J. P. S., & Kocher, H. M. (2025). Developing cell-based therapies for pancreatic ductal adenocarcinoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci189513
Vancouver
Fincham REA, Yeong JPS, Kocher HM. Developing cell-based therapies for pancreatic ductal adenocarcinoma. Journal of Clinical Investigation. 2025. doi:10.1172/jci189513
BibTeX
@article{Fincham2025,
author = {Fincham, Rachel Elizabeth Ann and Yeong, Joe Poh Sheng and Kocher, Hemant Mahendrakumar},
title = {Developing cell-based therapies for pancreatic ductal adenocarcinoma},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci189513}
}
EUVIMED